Mechanism of Action of Empagliflozin
Introduction Empagliflozin is an oral sodium–glucose co-transporter 2 (SGLT2) inhibitor that lowers blood glucose by promoting urinary glucose … Read more
Heart Failure Treatment
Mechanism of Action of Dapagliflozin
Introduction Dapagliflozin is an oral sodium–glucose co-transporter 2 (SGLT2) inhibitor, used to treat type 2 diabetes mellitus (T2DM). … Read more
Mechanism of Action of Jardiance (Empagliflozin)
Introduction Jardiance (empagliflozin) is a sodium–glucose co-transporter 2 (SGLT2) inhibitor used for type 2 diabetes mellitus (T2DM), heart failure … Read more
Mechanism of Action of Spironolactone
Introduction Spironolactone is a potassium-sparing diuretic and aldosterone antagonist used primarily in the treatment of heart failure, hypertension, … Read more